Sangrix Inc. Cash Flow-to-Debt Ratio
Sangrix Inc. cash flow-to-debt ratio. Sangrix Inc. (SGRX) has a Cash Flow-to-Debt Ratio of -0.14x as of March 2026, meaning its operating cash flow of $-2.09 Million could theoretically repay 0% of its total liabilities ($14.72 Million) in one year. See how financially flexible is Sangrix Inc. to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Sangrix Inc. (2022–2025)
Cash flow-to-debt ratio of Sangrix Inc. from 2022 to 2025. Historical debt coverage capacity for Sangrix Inc. across 4 annual periods. Check Sangrix Inc. cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Sangrix Inc. Cash Flow-to-Debt Ratio by Year (2022–2025)
Sangrix Inc. cash flow-to-debt ratio by year from 2022 to 2025. Year-by-year debt coverage analysis for Sangrix Inc.. For the full cash flow conversion analysis, see Sangrix Inc. (SGRX) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -6.16x | $-2.29 Million | $372.08K | ▼ -348.4% |
| 2024 | -1.37x | $-7.93 Million | $5.78 Million | ▲ +37.6% |
| 2023 | -2.20x | $-6.76 Million | $3.07 Million | ▲ +95.4% |
| 2022 | -47.46x | $-14.24 Million | $299.97K | — |